Successful treatment of onychomycosis with ciclopirox nail lacquer: a case report.
Onychomycosis commonly causes patients to seek medical care. Its unpleasant cosmetic appearance and negative impact on a patient's quality of life often prompt these visits. Onychomycosis rarely resolves spontaneously and has a high rate of recurrence. Although a variety of treatment options are available, inconsistent results and poor patient compliance have often hindered their success. We report the case of a 75-year-old man with moderate-to-severe onychomycosis who was treated successfully with ciclopirox nail lacquer solution 8%, the first topical antifungal agent approved by the Food and Drug Administration for the treatment of this disease.
Galitz
J
J
Doctors' Hospital Medical Center, Hollywood, Florida, USA.
D000287:Administration, Topical; D000368:Aged; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000077768:Ciclopirox; D005533:Foot Dermatoses / Q000188:drug therapy*; D006801:Humans; D008297:Male; D014009:Onychomycosis / Q000188:drug therapy*; D011728:Pyridones / Q000008:administration & dosage / Q000627:therapeutic use*
D000935:Antifungal Agents; D011728:Pyridones; D000077768:Ciclopirox